Literature DB >> 35033998

Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.

Marco Fornaro1, Vincenzo Venerito1, Florenzo Iannone2, Fabio Cacciapaglia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35033998     DOI： 10.3899/jrheum.210863

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.

Authors:  Yan Xie; Yang Liu; Yi Liu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD.

Authors:  Iulia Roman; Ioana Andreica; Xenofon Baraliakos; Imke Redeker; Uta Kiltz; Jürgen Braun
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-06-10       Impact factor: 3.625

3.  Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.

Authors:  Edoardo Conticini; Miriana d'Alessandro; Silvia Grazzini; Marco Fornaro; Daniele Sabella; Giuseppe Lopalco; Federico Giardina; Serena Colafrancesco; Chiara Rizzo; Giuliana Guggino; Roberta Priori; Fabrizio Conti; Florenzo Iannone; Elena Bargagli; Luca Cantarini; Bruno Frediani
Journal:  Intern Emerg Med       Date:  2022-06-26       Impact factor: 5.472
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.